SLI381: a long-acting psychostimulant preparation for the treatment of attention-deficit hyperactivity disorder

Bibliography

• National Prescription Audit. IMS, London, UK (2000).
   Google Scholar
• BRADLEY C: Benzedrine and dexedrine in the treatment of children's behaviour disorders. Pediatrics (1950) 5:24–36.
   PubMed Web of Science ®Google Scholar
• DULCAN M: Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit/ hyperactivity disorder. I Am. Acad. Child Adolesc. Psychiatry (1997) 36(10 Suppl): 85S–121S.
   Google Scholar
• •Summarises the current standard of care in pharmacotherapy of ADHD patients.
   Google Scholar
• PLISZKA SR, GREENHILL LL, CRISMON ML et al: The Texas children's medication algorithm project: report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part II: Tactics. j Am. Acad. Child Adolesc. Psychiatry (2000) 39:920–927.
   PubMed Web of Science ®Google Scholar
• •Summarises the current standard of care in pharmacotherapy of ADHD patients.
   Google Scholar
• SWANSON J, WIGAL S, GREENHILL LL et al.: Analogue classroom assessment of Adderall in children with ADHD. j Am. Acad. Child Adolesc. Psychiatry(1998) 37:519–526.
   PubMed Web of Science ®Google Scholar
• PELHAM WE, ARONOFF HR, MIDLAM JK et al: A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics (1999) 103:e43.
   PubMed Web of Science ®Google Scholar
• PELHAM WE, GNAGY EM, CHRONIS AM etal.: A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times daily methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics (1999) 104:1300-1311.
   Google Scholar
• MANOS MJ, SHORT EJ, FINDLING RL:Differential effectiveness of methylphenidate and Adderall® in school-age youths with attention-deficit/hyperactivity disorder. Ain. Acad. Child Adolesc. Psychiatry (1999) 38:813–819.
   PubMed Web of Science ®Google Scholar
• PLISZKA SR, BROWN RG, OLVERA RL et al: A double blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. j Am. Acad. Child Adolesc. Psychiatry (2000) 39:619–626.
   PubMed Web of Science ®Google Scholar
• GRCEVICH SJ, ROWANE, WA, MARCELLINO B et al.:Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder. j Child Adolesc. Psychopharmacol .(2001)11:35–41.
   PubMed Web of Science ®Google Scholar
• GREENHILL LL, ABIKOFF HB, ARNOLD LE et al.: Medication treatment strategies in the MTA study: relevance to clinicians and researchers. j Am. Acad. Child Adolesc. Psychiatry (1996) 35:1304-1313.
   Google Scholar
• ARNOLD LE: Methylphenidate vs. amphetamine: comparative review. Attention Disorders (2000) 3:200–211.
   Google Scholar
• •Meta-analysis of all controlled comparison studies contrasting amphetamine-based and methylphenidate-based stimulants.
   Google Scholar
• BERKOVITCH M, POPE E, PHILLIPS J et al.: Pemoline-associated fulminant hepatic failure: testing the evidence for causation. Pharmacol Ther. (1995) 57:696-698.
   Google Scholar
• SAFER D, ZITO JM, GARDNER JE: Pemoline hepatotoxicity and postmarketing surveillance. j Am. Acad. Child Adolesc. Psychiatry (2001) 40:622–629.
   PubMed Web of Science ®Google Scholar
• FARAONE S, PLISZKA SR, OLVERA RL et al.: Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a reanalysis using drug-placebo and drug-drug response curve methodology. I Child Adolesc. Psychopharmacol (2001) 11:171-180.
   Google Scholar
• JAMES RS, WALTER JM, SHARP WS et al.: Comparative efficacy of 3 amphetamine preparations in children with ADHD. 47th Annual Meeting of the American Academy of Child am Adolescent Psychiatry New York, NY, USA (24–29 October 2000) (Poster).
   Google Scholar
• ARNOLD LE, HUESTIS RD, SMELTZER DJ etal.: Levoamphetamine vs. dextroamphetamine in minimal brain dysfunction. Arch. Gen. Psychiatry (1976) 33:292–301.
   Google Scholar
• MIRZA WU, RAK IW, THADANI VM et al.: Six month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures. Neurology (1998) 51:1727-1729.
   Google Scholar
• McCRACKEN JT, BIEDERMAN J, GREENHILL LL etal.: Analogue classroom assessment of SLI381 for the treatment of ADHD. 47h Annual Meeting of the American Academy of Child am Adolescent Psychiatry New York, NY, USA (October 24–29, 2000) (Poster).
   Google Scholar
• ••Represents a completed study of SLI381 inthe public domain.
   Google Scholar
• BIEDERMAN J: Once-daily dosed SLI-381 for pediatric ADHD. 41st Annual Meeting of the NIMH New Clinical Drug evaluation Unit. Phoenix, AZ, USA (May 28–31 2001) (Poster).
   Google Scholar
• ••Represents a completed study of SLI381 inthe public domain.
   Google Scholar